Alisertib for Acute Myeloid Leukemia

NCT01779843 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: Cytarabine
DRUG: Idarubicin
DRUG: Alisertib

Sponsor

Massachusetts General Hospital